WebIt is advisable to monitor prolactin concentration at the start of therapy, at 6 months, and then yearly. Patients taking antipsychotic drugs not normally associated with symptomatic hyperprolactinaemia should be considered for prolactin monitoring if they show symptoms of hyperprolactinaemia (such as breast enlargement and galactorrhoea). WebDrug monitoring The tables below show the monitoring requirements of common drugs. It should be noted these are basic guidelines and do not relate to monitoring …
Review February 2024 Drug Monitoring Recommendations
WebAnxiety; appetite increased; arthralgia; back pain; confusion; constipation; diarrhoea; dizziness; drowsiness; dry mouth; fatigue; headache (on discontinuation); myalgia; nausea; oedema; postural hypotension; sleep disorders; tremor; vomiting; weight increased Uncommon Hallucination; mania; movement disorders; oral disorders; syncope WebSafe Use of Lithium in Adults Shared Care Protocol This protocol provides prescribing and monitoring guidance for lithium therapy. It should be read in conjunction with the … income tax india filing new portal
Therapeutic Drug Monitoring
Web4 okt. 2024 · Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression. It is used as a mood … WebApproved by Drug & Therapeutics Committee Date of Approval 27. th. July 2024 – updated 11. th. Sept 2024 Protocol Number PHARM-0024-v7.1 Date of Review 01 February 2024 … Web31 mei 2024 · It is recommended that patients’ renal function be closely monitored during lithium therapy. Obesity: Lithium clearance is significantly greater for obese patients … income tax india home